Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06820515 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ATHNdataset Registry

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Enrolling by Invitation to Recruiting
    • Site details revised
    v4
  2. Study title shortened, about 5 wordsv3
  3. Primary endpoint revised
    • Secondary endpoint revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Hemophilia Treatment Center (HTC) where you receive care is working with The American Thrombosis and Hemostasis Network (ATHN) to look at the quality of life of people with blood disorders and problems. Doctors, scientists, policymakers, and other health care providers need a large amount of information from a lot of people to answer scientific, public health, and policy questions about better ways to treat blood disorders. They will use the information from the ATHNdataset to answer these questions.
Trial Details
NCT Number NCT06820515
Lead Sponsor American Thrombosis and Hemostasis Network
Conditions
(from sponsor)		 Hemophilia, Thrombosis, Hemophilia A, Hemophilia B, Sickle Cell Disease, Glanzmann Thrombasthenia, Bleeding Disorder, Blood Disorder +1 more
Related terms Anemia, Sickle Cell, Hemarthrosis, Hematologic Diseases, Hemophilia A, Hemophilia B, Hemostatic Disorders, Thrombasthenia, Thrombosis, von Willebrand Diseases
Enrollment 200,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov